The Joint Congress of ESPE and ESE proudly presents this years' awardees.
Congratulations to the worthy winners!
Endocrinology Across the Life Course Award winner
Sadaf Farooqi (United Kingdom)
Henning Andersen Award winners
Luis Gustavo Perez-Rivas (Germany)
Jinting Zhou (China)
People’s Choice Award winners
Mert Ucar (Turkey)
Anna Matveeva (Switzerland)
María Isabel Pozo-Relaño (Spain)
ESE Young Investigator Award winners
Merisa Abusdal (Norway)
The roles of PDLIM1 in silent corticotroph adenomas aggressiveness
Anna Angelousi (Greece)
Immune-related hypophysitis and imaging: A distinct type of hypophysitis?
Muhammad Fahad Arshad (United Kingdom)
Severe Hyponatraemia in Europe: Insights into Endocrinologists’ Clinical Practices and Perspectives
Valeria Citterio (Italy)
Pathophysiology of osteoporosis (PATHOS Study): role of hidden cortisol excess (HidHyCo) and its predictors in bone fragility, preliminary results
Álvaro Flores-Martínez (Spain)
Exploration of Pituitary Stem Cells heterogeneity and their contribution in Gonadotroph Tumors
Lucía Iglesias García (Argentina)
Nuclear Factor I/B Interaction with PROP1 and its Role in Pituitary Cell Differentiation
James Kaufman-Cook (United Kingdom)
SDHB loss in anterior pituitary embryonic progenitors and postnatal SOX2+ stem cells is insufficient to drive pituitary tumorigenesis and results in pituitary hypoplasia in mice
Tinatin Kutchukidze (Georgia)
Smart Menstrual Health Monitoring Patch: A non-invasive AI-driven Solution for Cycle Tracing
Alessandra Mangone (Italy)
Clinical Predictors of Treatment Response in Advanced Adrenocortical Carcinoma: a multicentre ENSAT study
Mikkel Thor Olsen (Denmark)
In-hospital diabetes management by a diabetes team using insulin algorithms with continuous glucose monitoring or point-of-care testing in patients with type 2 Diabetes: the DIATEC RCT
Cem Sulu (Turkey)
The Personality Profile and Neurostructural Associations in Patients with Cushing’s Disease
Zhuolun Sun (Germany)
Single-Cell, Single-Nucleus, and Spatial Transcriptomics Reveal the Cellular Atlas and Developmental Mechanisms of Aldosterone-Producing Micronodules and Adenomas
ESPE Undergraduate Achievement Award winners
Henri Couckuyt (Belgium)
Lena Van de Wynkele (Belgium)
Poster Award winners
Mohamed Abubaker (United Kingdom)
Validation of prognostic biomarkers in adrenocortical carcinoma through a Next-Generation Sequencing in real-life setting.
Merisa Abusdal (Norway)
The roles of PDLIM1 in silent corticotroph adenomas aggressiveness
Corin Badiu (Romania)
Relacorilant Improved Blood Pressure and Maintained Other Cardiometabolic Improvements in Long-term Study in Patients With Endogenous Hypercortisolism (Cushing Syndrome)
Felix Chelslin (Sweden)
Differential expression and protein abundance of key regulators of the IGF, adiponectin and PPAR signalling pathways in placentas from small, adequate and large for gestational age newborns.
Nathalie Erpelding (United States of America)
48-Week Results from the HELIOS Trial: A Phase 2, Open-Label Study Evaluating an Oral, Fixed-Dose Combination of Sodium Phenylbutyrate and Taurursodiol in Wolfram Syndrome
Isabel Viola Frielitz-Wagner (Germany)
Diabetes type 1 can induce testicular atrophy with Leydig cell hyperplasia and germ cell depletion and therefore negatively influence reproductive function in rats
Laura Lucaccioni (Italy)
Impact of early-life exposure to phthalates on anogenital distances in a cohort of healthy children and their mothers, from birth to three years of age.
Malene Asp Bock Mejdahl (Denmark)
Reproductive hormones in infertile men with Y chromosome microdeletions
Sema Okutan (Denmark)
Stimulated peak cortisol in healthy paticipants measured during the insulin tolerance test: defining cut-off limits for adrenal insufficiency with two generations of Roche cortisol immunoassays
Luigi Picaro (United Kingdom)
Consistent Reduction in Rate of Fracture with Setrusumab Therapy in Patients with Osteogenesis Imperfecta: Month 14 Data from Phase 2 of the Orbit Study
Philippa Prentice (United Kingdom)
Parathyroid surgery in children with Sporadic and Familial Hyperparathyroidism
Mercedes Rivera Cuello (Spain)
Setmelanotide in the Management of Pediatric Obesity due to Genetic Disorders: Clinical Response and Quality of Life Assessment
Patrice Rodien (France)
THRIVE-2 Phase 3 Trial of Veligrotug (VRDN-001) in Chronic Thyroid Eye Disease (TED): Efficacy and Safety at 15 Weeks
Carin Skogastierna (Sweden)
Early life growth is important for pubertal growth and adult height
Lorenzo Tucci (Italy)
Measurement of circulating cell-free DNA concentrations for differential diagnosis of adrenal masses: a pilot study.
Yi Wang (China)
Genetic basis of patients with congenital gonadotropin deficiency
Each year ESPE and ESE celebrate the best in endocrinology through our Award Programmes.
New Joint ESPE and ESE Award
The new Joint ESPE and ESE ‘Endocrinology Across the Life Course Award’ is a prestigious recognition awarded to clinicians and basic scientists who have made significant contributions to endocrinology across the life course.
Read more about this new award.
Our Joint 2025 Congress provides a great opportunity for you to present your work to over 6,000 colleagues, and to be eligible for one of these Awards. We look forward to receiving your abstracts and wish you every success with your submission.
Joint abstract prizes
The Henning Andersen Prizes are two awards for the most highly rated clinical, basic and translational abstracts submitted to the Joint Congress.
Support – The Henning Andersen Prizes are made possible by the generous support of Novo Nordisk.
Poster Awards, worth €250 each, are awarded to the 16 best posters on display at the Joint Congress.
The 16 awarded posters are selected from the top 30 posters which attained the best ratings during the abstract evaluation process, based on the scientific content and on the quality of the poster presentation. The prizes are bestowed by the Joint Programme Organising Committee to the presenting author of the 16 selected posters.
People’s choice awards, worth €250, are awarded to the best clinical, basic and translational abstract voted by delegates and the Joint Programme Organising Committee. The three top abstracts from each category (clinical, basic and translational) are shortlisted and delegates are then able to vote for their favourite. Delegates votes will count for 50% of the score, with the other 50% coming from the Joint Programme Organising Committee.
ESPE and ESE Society specific abstract awards
The ESPE Undergraduate Achievement Award aims to attract early-career scientists and clinicians into paediatric endocrinology by recognising high achievement in the field. This award is open to all undergraduates, medical and non-medical, and is awarded for scientific achievement in the specific field of paediatric endocrinology.
The ESE Young Investigator Awards (of €1,000 each) are given to 12 early career researchers at ESE’s annual Congress (for 2025 the Joint Congress of ESPE and ESE). The Young Investigator Awards are open to researchers who submit either a basic science or clinical abstract to the annual Congress. Researchers must be ESE members and within 10 years post-PhD or MD. Application is through the abstract submission form and is awarded to those with the highest abstract scores.
Criteria: impact on early development or ageing or both/ impact from childhood to older age
For the Joint Congress of ESPE and ESE, we are introducing a brand new joint society award – The NAME Award. (name tbc).
We look forward to receiving your nominations for this exciting new award. The winner will be announced in February 2025, and the awardee will be asked to present their plenary lecture during the Opening Ceremony at the Joint Congress of ESPE and ESE 2025 ‘Connecting Endocrinology Across the Life Course’ when they will also be presented with their award.
Nominees should be a member of either ESPE or ESE. Self-nominations will be accepted if supported by two ESPE or ESE members. To nominate or apply, please send a letter of endorsement outlining the suitability of the candidate for the award, together with a CV to xxxx.
All applications must be received by Monday 6 January 2025 (23:59 CET).
